Literature DB >> 33862043

Reflections on the unexpected laboratory finding of hemorheological alterations observed in some haematological disorders.

Gregorio Caimi1, Rosalia Lo Presti2, Melania Carlisi3.   

Abstract

Hyperviscosity syndrome is a clinical condition characterized by the slowing of blood flow through the vessels and it may be associated with several diseases. The nosographic classification of primary hyperviscosity conditions (Wells classification 1970) divided the primary hyperviscosity syndromes in polycythaemic, sclerocytemic and sieric. Recent and personal laboratory observations have highlighted an unexpected behaviour of the erythrocyte deformability observed in some haematological disorders such as polycythemia vera, multiple myeloma and monoclonal gammopathy of undetermined significance. The interest of this observation depends on the fact that up to now, according to the Wells classification, the hemorheological alteration present in PV was related to the increase of RBC mass while that present in MM and MGUS was attributable to the abnormality of plasma or serum viscosity only. Through an extensive research among the literature, using MEDLINE/PubMed to identify all published reports on the hyperviscosity syndromes, issues that until now have been dealt with separately will therefore be analyzed in a unique paper, allowing a global view. The aim of this paper is to provide some suggestions for reflection and emphasizing the need of a nosographic framework of hyperviscosity that, probably, deserves to be reviewed.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hyperviscosity syndromes; Monoclonal gammopathy of undetermined significance; Multiple myeloma; Polycythemia vera

Mesh:

Year:  2021        PMID: 33862043     DOI: 10.1016/j.mvr.2021.104171

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  1 in total

Review 1.  High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations.

Authors:  Melania Carlisi; Salvatrice Mancuso; Rosalia Lo Presti; Sergio Siragusa; Gregorio Caimi
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.